ESPOSITO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.290
EU - Europa 1.781
AS - Asia 1.389
AF - Africa 225
SA - Sud America 77
OC - Oceania 11
Totale 7.773
Nazione #
US - Stati Uniti d'America 4.246
IT - Italia 948
SG - Singapore 903
IN - India 228
CN - Cina 185
FI - Finlandia 140
TG - Togo 107
NG - Nigeria 105
UA - Ucraina 103
DE - Germania 101
RU - Federazione Russa 98
SE - Svezia 80
FR - Francia 58
AT - Austria 54
BG - Bulgaria 53
BR - Brasile 45
GB - Regno Unito 42
CA - Canada 37
AR - Argentina 28
IE - Irlanda 28
ID - Indonesia 23
NL - Olanda 22
BE - Belgio 16
PK - Pakistan 13
AU - Australia 10
ES - Italia 10
HK - Hong Kong 8
RO - Romania 8
TR - Turchia 8
ZA - Sudafrica 7
CH - Svizzera 6
LT - Lituania 6
CL - Cile 4
JP - Giappone 4
EG - Egitto 3
GR - Grecia 3
MX - Messico 3
PH - Filippine 3
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
MV - Maldive 2
MY - Malesia 2
OM - Oman 2
SC - Seychelles 2
BD - Bangladesh 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SV - El Salvador 1
Totale 7.773
Città #
Fairfield 674
Singapore 464
Rome 359
Woodbridge 346
Chandler 344
Ashburn 337
Houston 296
Seattle 241
Wilmington 206
Cambridge 205
Ann Arbor 174
Princeton 120
Santa Clara 118
San Paolo di Civitate 114
Lomé 107
Plano 90
Dearborn 75
Lawrence 73
Boston 69
Beijing 60
Helsinki 57
Sofia 53
Millbury 46
Vienna 44
San Diego 42
Grafing 38
Jacksonville 34
Falkenstein 32
Cosenza 29
Moscow 29
Dublin 28
Federal 28
Toronto 28
Boardman 26
Andover 24
Jakarta 23
Milan 21
Norwalk 20
Los Angeles 16
Council Bluffs 14
Nanjing 14
Kunming 13
Naples 13
Brussels 12
Padova 11
Rio de Janeiro 11
Des Moines 10
Salerno 10
Teramo 10
Karachi 9
Melbourne 9
Fiano Romano 8
Nanterre 8
San Mateo 8
Anguillara 7
Falls Church 7
Guangzhou 7
Istanbul 7
Lavello 7
Legnano 7
London 7
Shanghai 7
Laurel 6
Napoli 6
Wuhan 6
Bologna 5
Dobbs Ferry 5
Frankfurt am Main 5
Hefei 5
Hong Kong 5
Jinan 5
Nanchang 5
New York 5
Nuremberg 5
Phoenix 5
Turin 5
Yubileyny 5
Boydton 4
Bühl 4
Delhi 4
Florence 4
Fuzhou 4
Genoa 4
Indiana 4
Lappeenranta 4
Modena 4
Newton Upper Falls 4
Ottawa 4
Pune 4
Vedelago 4
Viterbo 4
Washington 4
Buffalo 3
Catania 3
Changsha 3
Cumignano sul Naviglio 3
Hebei 3
Hoogstraten 3
Hyderabad 3
Maddaloni 3
Totale 5.468
Nome #
Next-Generation Probiotics for Inflammatory Bowel Disease 202
Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegeneration 135
inPentasomes: an innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice 117
Palmitoylethanolamide modulates inflammation-associated vascular endothelial growth factor (VEGF) signaling via the Akt/mTOR pathway in a selective peroxisome proliferator-activated receptor alpha (PPAR-α)-dependent manner. 110
Allele-specific transcriptional activity of the variable number of tandem repeats of the inducible nitric oxide synthase gene is associated with idiopathic achalasia 110
Engineered lactobacillus paracasei producing palmitoylethanolamide (PEA) prevents colitis in mice 109
Lathyrus sativus diamine oxidase reduces clostridium difficile toxin a-induced toxicity in caco-2 cells by rescuing rhoa-gtpase and inhibiting pp38-mapKknf-κb/hif-1α activation 101
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line caco-2 100
null 99
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide 98
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection 97
Dietary methods using lactobacillus paracasei subsp. paracasei f19 as nape-pld gene carrier for producing on demand pea or oea and relative biological dietary compositions thereof 95
Rifaximin improves clostridium difficile toxin A-induced toxicity in caco-2 cells by the PXR-dependent TLR4/MyD88/NF-κB pathway 94
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway 93
Enteric glia: a new player in inflammatory bowel diseases 92
Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. 92
Ultramicronized palmitoylethanolamide inhibits NLRP3 inflammasome expression and pro-inflammatory response activated by SARS-CoV-2 spike protein in cultured murine alveolar macrophages 92
Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders 91
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 90
S100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer's disease 90
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells 88
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 87
HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system 87
A palmitoylethanolamide producing lactobacillus paracasei improves clostridium difficile toxin a-induced colitis 87
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 85
Opposing control of cannabinoid receptor stimulation on amyloid-{beta} induced reactive gliosis: in vitro and in vivo evidence. 85
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 84
New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors. 83
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes 83
Endocannabinoid-related compounds in gastrointestinal diseases 82
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α 82
ADELMIDROL, A PALMITOYLETHANOLAMIDE ANALOG, REDUCES CHRONIC INFLAMMATION IN A CARRAGEENIN-GRANULOMA ODEL IN RATS 81
Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases 81
Aplidiasterols A and B, two new cytotoxic 9,11-secosterols from the mediterranean ascidian Aplidium conicum 79
Selective CB2 up-regulation in women affected by endometrial inflammation 79
Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease 78
Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue 78
S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. 77
Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression 77
S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells 77
S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors 75
Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. 74
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors 74
Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line 74
Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders? 72
The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice 72
Phytotherapics in COVID19: why palmitoylethanolamide? 71
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-kappaB activation. 70
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation 70
Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. 69
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. 69
The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity 68
Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. 68
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation 68
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats 68
Induction of nitric oxide synthase expression by Withania somnifera in macrophages 67
Oxalomalate affects the inducible nitric oxide synthase expression and activity 67
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement 66
CB1 receptor selective activation inhibits β-amyloid-induced Inos protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons 65
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ? 65
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis 65
null 62
S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation 60
Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion? 60
null 60
Nutraceuticals and diet supplements in Crohn’s Disease. A general overview of the most promising approaches in the clinic 59
Cannabinoid CB(1) receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. 58
Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection 58
The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. 57
Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement 57
Acetonic extract from the feijoa sellowiana berg. fruit exerts antioxidant properties and modulates disaccharidases activities in human intestinal epithelial cells 57
Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. 56
Novel bioactive sulfated alkene and alkanes from the Mediterranean ascidian Halocynthia papillosa 56
OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors 56
Cannabidiol in vivo suppresses Aβ-induced reactive gliosis. 54
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB(1) receptors and fatty acid amide hydrolase 53
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview 52
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARSCoV- 2 spike protein-induced lung injury in mice 51
S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein up-regulation and relative Wnt pathway disruption in cultured human neurons. 51
Minor steroidal alkaloids from the marine sponge Corticium sp. 49
Possibile ruolo delle ALIAmidi nelle patologie degenerative del sistema nervoso. 48
Young Researcher Award 2019 - Dipartimento di Fisiologia e Farmacologia "V. Erspamer", Università Sapienza di Roma 48
S100B protein stimulates proliferation and angiogenic mediators release through RAGE/pAkt/mTOR pathway in human colon adenocarcinoma Caco-2 Cells 47
BIOLOGICAL COMPOSITION BASED ON ENGINEERED LACTOBACILLUS PARACASEI SUBSP. PARACASEI F19 FOR THE BIOSYNTHESIS OF CANNABINOIDS 46
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 46
PPARγ mediates cannabidiol antiinflammatory and neuroprotective effects in an in vitro model of Alzheimer’s disease. 45
Genomic and functional profiling of human Down syndrome neural progenitor implicates S100B and Aquaporin 4 in cell injury 44
Turbinamide, a new selective cytotoxic agent from the Mediterranean tunicate Sidnyum turbinatum. 44
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 44
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. 44
PHARMACOGNOSY, PHYTOTHERAPY AND ENTERIC SYSTEM PHARMACOLOGY: INNOVATIVE APPROACHES FOR GREEN PHARMACOLOGICAL STRATEGIES 43
Palmitoylethanolamide counteracts reactive gliosis in an in vivo model of Alzheimer’s disease 43
The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation 43
Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms 42
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 41
Palmitoylethanolamide is able to attenuate astrocyte activation and neuroinflammation in models of Alzheimer’s desease 41
Antinflammatory/neuroprotective properties of palmitoylethanolamide in a model of Alzheimer’s disease 40
null 39
Cannabidiol controls intestinal inflammation through the modulation of enteric glial cell activation. 38
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 38
Totale 7.134
Categoria #
all - tutte 25.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 332
selected - selezionate 0
volume - volumi 0
Totale 25.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020357 0 0 0 0 0 0 0 0 132 76 47 102
2020/2021594 68 77 40 40 18 50 9 48 85 74 57 28
2021/20221.389 18 66 118 37 156 147 28 130 102 101 273 213
2022/20231.324 234 336 61 119 154 123 25 65 105 20 61 21
2023/2024904 36 90 26 53 201 106 26 64 16 118 82 86
2024/20251.452 69 82 68 92 208 221 125 96 491 0 0 0
Totale 8.055